Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Birnbaum

Showing results (121-130 of 344) with videos related to

Pageof 35
Sort By:
Blood|September 13, 2003
FOP-FGFR1 tyrosine kinase, the product of a t(6;8) translocation, induces a fatal myeloproliferative disease in miceGeraldine Guasch, Bénédicte Delaval, Christine Arnoulet, et al.
Cancer Genomics & Proteomics|July 9, 2011
Gene expression profiling and its utility in prediction of local relapse after breast-conserving therapy in early breast cancerRenaud Sabatier, Pascal Finetti, Nathalie Cervera, et al.
Journal of Cellular Biochemistry|July 7, 2020
ERBB2b mRNA isoform encodes a nuclear variant of the ERBB2 oncogene in breast cancerGuoqiang Hua, Aurélie Bergon, Pierre Cauchy, et al.
Medecine Sciences : M/S|May 19, 2006
[Genetic factors and colorectal cancers development: therapeutic impact]Sylviane Olschwang, Frédéric Viret, Geneviève Monges, et al.
Breast Cancer Research : BCR|January 7, 2009
CD146 expression is associated with a poor prognosis in human breast tumors and with enhanced motility in breast cancer cell linesGwladys Zabouo, Anne-Marie Imbert, Jocelyne Jacquemier, et al.
Oncogene|August 8, 2002
Carcinogenesis and translational controls: TACC1 is down-regulated in human cancers and associates with mRNA regulatorsNathalie Conte, Emmanuelle Charafe-Jauffret, Bénédicte Delaval, et al.
Plos One|November 24, 2011
Down-regulation of ECRG4, a candidate tumor suppressor gene, in human breast cancerRenaud Sabatier, Pascal Finetti, José Adelaide, et al.
Cancers|August 16, 2019
A Tyrosine Kinase Expression Signature Predicts the Post-Operative Clinical Outcome in Triple Negative Breast CancersAlexandre de Nonneville, Pascal Finetti, José Adelaide, et al.
International Journal of Cancer|September 26, 2008
Absence of ESR1 amplification in a series of breast cancersJosé Adélaïde, Pascal Finetti, Emmanuelle Charafe-Jauffret, et al.
In Vivo (Athens, Greece)|May 6, 2009
Abnormal mammary gland development in MMTV-CBLC transgenic mouseFrédéric Fiore, Bruno Estebe, Patrick Gibier, et al.
Pageof 35

Showing results (121-130 of 344) with videos related to

Sort By:
Pageof 35
Blood|September 13, 2003
FOP-FGFR1 tyrosine kinase, the product of a t(6;8) translocation, induces a fatal myeloproliferative disease in miceGeraldine Guasch, Bénédicte Delaval, Christine Arnoulet, et al.
Cancer Genomics & Proteomics|July 9, 2011
Gene expression profiling and its utility in prediction of local relapse after breast-conserving therapy in early breast cancerRenaud Sabatier, Pascal Finetti, Nathalie Cervera, et al.
Journal of Cellular Biochemistry|July 7, 2020
ERBB2b mRNA isoform encodes a nuclear variant of the ERBB2 oncogene in breast cancerGuoqiang Hua, Aurélie Bergon, Pierre Cauchy, et al.
Medecine Sciences : M/S|May 19, 2006
[Genetic factors and colorectal cancers development: therapeutic impact]Sylviane Olschwang, Frédéric Viret, Geneviève Monges, et al.
Breast Cancer Research : BCR|January 7, 2009
CD146 expression is associated with a poor prognosis in human breast tumors and with enhanced motility in breast cancer cell linesGwladys Zabouo, Anne-Marie Imbert, Jocelyne Jacquemier, et al.
Oncogene|August 8, 2002
Carcinogenesis and translational controls: TACC1 is down-regulated in human cancers and associates with mRNA regulatorsNathalie Conte, Emmanuelle Charafe-Jauffret, Bénédicte Delaval, et al.
Plos One|November 24, 2011
Down-regulation of ECRG4, a candidate tumor suppressor gene, in human breast cancerRenaud Sabatier, Pascal Finetti, José Adelaide, et al.
Cancers|August 16, 2019
A Tyrosine Kinase Expression Signature Predicts the Post-Operative Clinical Outcome in Triple Negative Breast CancersAlexandre de Nonneville, Pascal Finetti, José Adelaide, et al.
International Journal of Cancer|September 26, 2008
Absence of ESR1 amplification in a series of breast cancersJosé Adélaïde, Pascal Finetti, Emmanuelle Charafe-Jauffret, et al.
In Vivo (Athens, Greece)|May 6, 2009
Abnormal mammary gland development in MMTV-CBLC transgenic mouseFrédéric Fiore, Bruno Estebe, Patrick Gibier, et al.
Pageof 35